| Year |
Citation |
Score |
| 2024 |
Tseng TC, Cheng HR, Su TH, Lin PH, Wang CC, Yang HC, Tsai CS, Liu CJ, Chen PJ, Kao JH. Higher hepatitis B core-specific T cell response is associated with a lower risk of clinical relapse after discontinuation of oral antiviral treatment. Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi. PMID 39153879 DOI: 10.1016/j.jmii.2024.07.012 |
0.333 |
|
| 2023 |
Lui GC, Wong GL, Yang HC, Sheng WH, Lee SH. Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia. Hiv Medicine. PMID 37735948 DOI: 10.1111/hiv.13545 |
0.456 |
|
| 2021 |
Cheng HR, Yang HC, Lin SR, Yang TY, Lin YY, Su TH, Tseng TC, Liu CJ, Kao JH. Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients. Hepatology International. PMID 34562189 DOI: 10.1007/s12072-021-10245-z |
0.303 |
|
| 2021 |
Cheng HR, Yang HC, Lin SR, Yang TY, Lin YY, Su TH, Tseng TC, Liu CJ, Kao JH. Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients. Hepatology International. PMID 33886088 DOI: 10.1007/s12072-021-10186-7 |
0.322 |
|
| 2020 |
Chen PJ, Kao JH, Liu CJ, Yang HC. In memoriam: Dr. Ding-Shinn Chen, 1943-2020. Hepatology (Baltimore, Md.). PMID 32767845 DOI: 10.1002/Hep.31505 |
0.322 |
|
| 2020 |
Yang HC, Kao JH. Towards elimination of viral hepatitis in Taiwan by 2025: In memory of Professor Ding-Shinn Chen (1943-2020). Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 32654867 DOI: 10.1016/J.Jfma.2020.07.007 |
0.311 |
|
| 2020 |
Su HJ, Kao JH, Tseng TC, Yang HC, Su TH, Chen PJ, Liu CJ. Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 32499209 DOI: 10.1016/J.Jfma.2020.05.027 |
0.37 |
|
| 2020 |
Tseng TC, Peng CY, Hsu YC, Su TH, Wang CC, Liu CJ, Yang HC, Yang WT, Lin CH, Yu ML, Lai HC, Tanaka Y, Nguyen MH, Liu CH, Chen PJ, et al. Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy. Liver Cancer. 9: 207-220. PMID 32399434 DOI: 10.1159/000504650 |
0.307 |
|
| 2020 |
Chang WY, Chiu YC, Chiu FW, Hsu YC, Tseng TC, Cheng PN, Yang SS, Liu CJ, Su TH, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH. High Risk of clinical relapse in HBV-infected patients after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy. The Journal of Infectious Diseases. PMID 32396638 DOI: 10.1093/Infdis/Jiaa256 |
0.419 |
|
| 2020 |
Yang YC, Chen YH, Kao JH, Ching C, Liu IJ, Wang CC, Tsai CH, Wu FY, Liu CJ, Chen PJ, Chen DS, Yang HC. Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing. Molecular Therapy. Nucleic Acids. 20: 480-490. PMID 32278307 DOI: 10.1016/J.Omtn.2020.03.005 |
0.367 |
|
| 2020 |
Tseng TC, Liu CJ, Chang CT, Su TH, Yang WT, Tsai CH, Chen CL, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH. HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis. Journal of Hepatology. PMID 32006586 DOI: 10.1016/J.Jhep.2020.01.012 |
0.392 |
|
| 2019 |
Su TH, Tseng TC, Liu CJ, Chou SW, Liu CH, Yang HC, Chen PJ, Chen DS, Chen CL, Kao JH. Antiviral Therapy against Chronic Hepatitis C is Associated with a Reduced Risk of Oral Cancer. International Journal of Cancer. PMID 31853972 DOI: 10.1002/Ijc.32840 |
0.309 |
|
| 2019 |
Su TH, Yang HC, Tseng TC, Chou SW, Lin CH, Liu CH, Liu CJ, Chen CL, Kao JH. Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31505068 DOI: 10.1002/Mds.27848 |
0.306 |
|
| 2019 |
Tseng TC, Liu CJ, Hsu CY, Hong CM, Su TH, Yang WT, Chen CL, Yang HC, Huang YT, Fang-Tzu Kuo S, Liu CH, Chen PJ, Chen DS, Kao JH. High Level of Hepatitis B Core-related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load. Gastroenterology. PMID 31470004 DOI: 10.1053/J.Gastro.2019.08.028 |
0.381 |
|
| 2019 |
Tsou HH, Yang HC, Hsiao CF, Hsiung CA, Liu TW, Chuang MH, Wu HY, Hsu YT, Tsui CW, Chen PJ, Cheng AL, Hsu C. Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 31235201 DOI: 10.1016/J.Jfma.2019.05.027 |
0.418 |
|
| 2019 |
Liu CH, Su TH, Liu CJ, Hong CM, Yang HC, Tseng TC, Chen PJ, Chen DS, Kao JH. Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection. Journal of Gastroenterology and Hepatology. PMID 30693965 DOI: 10.1111/Jgh.14615 |
0.394 |
|
| 2019 |
Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH. Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma. Alimentary Pharmacology & Therapeutics. PMID 30681172 DOI: 10.1111/Apt.15132 |
0.31 |
|
| 2019 |
Wu LL, Peng WH, Wu HL, Miaw SC, Yeh SH, Yang HC, Liao PH, Lin JS, Chen YR, Hong YT, Wang HY, Chen PJ, Chen DS. Ly6C Monocytes and Kupffer Cells Orchestrate Liver Immune Responses Against Hepatitis B Virus in Mice. Hepatology (Baltimore, Md.). PMID 30661248 DOI: 10.1002/Hep.30510 |
0.385 |
|
| 2018 |
Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH. Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection. Alimentary Pharmacology & Therapeutics. PMID 30592071 DOI: 10.1111/Apt.15101 |
0.38 |
|
| 2018 |
Liu CH, Liu CJ, Su TH, Yang HC, Hong CM, Tseng TC, Chen PJ, Chen DS, Kao JH. Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan. Plos One. 13: e0209299. PMID 30576344 DOI: 10.1371/Journal.Pone.0209299 |
0.396 |
|
| 2018 |
Hong CM, Liu CH, Su TH, Yang HC, Chen PJ, Chen YW, Kao JH, Liu CJ. Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data. Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi. PMID 30316726 DOI: 10.1016/J.Jmii.2018.09.005 |
0.302 |
|
| 2018 |
Yang HC, Kao JH. Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus. Gut. PMID 30301771 DOI: 10.1136/Gutjnl-2018-317385 |
0.374 |
|
| 2018 |
Liu CH, Huang YJ, Yang SS, Chang CH, Yang SS, Sun HY, Liu CJ, Liu WC, Su TH, Yang HC, Hong CM, Tseng TC, Chen PJ, Chen DS, Hung CC, et al. Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study. Scientific Reports. 8: 13699. PMID 30209349 DOI: 10.1038/S41598-018-32060-7 |
0.378 |
|
| 2018 |
Liu CJ, Tseng TC, Yang WT, Su TH, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH. Profile and Value of FIB-4 in Patients with Dual Chronic Hepatitis C and B. Journal of Gastroenterology and Hepatology. PMID 30151861 DOI: 10.1111/Jgh.14455 |
0.389 |
|
| 2018 |
Yang HC, Tsou HH, Pei SN, Chang CS, Chen JH, Yao M, Lin SJ, Lin J, Yuan Q, Xia N, Liu TW, Chen PJ, Cheng AL, Hsu C. Quantification of HBV core antibodies may help predict HBV reactivation in lymphoma patients with resolved HBV infection. Journal of Hepatology. PMID 29551710 DOI: 10.1016/J.Jhep.2018.02.033 |
0.363 |
|
| 2018 |
Lin PH, Wong WI, Wang YL, Hsieh MP, Lu CW, Liang CY, Jui SH, Wu FY, Chen PJ, Yang HC. Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection. Mucosal Immunology. PMID 29467445 DOI: 10.1038/S41385-018-0004-9 |
0.339 |
|
| 2018 |
Liu C, Yang S, Yang S, Sun H, Liu C, Liu W, Su T, Yang H, Hong C, Tseng T, Chen P, Chen D, Hung C, Kao J. Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study Journal of Hepatology. 68: S266. DOI: 10.1016/S0168-8278(18)30745-1 |
0.303 |
|
| 2017 |
Yang HC, Shih YF, Liu CJ. Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B. The Journal of Infectious Diseases. 216: S757-S764. PMID 29156050 DOI: 10.1093/Infdis/Jix461 |
0.392 |
|
| 2017 |
Shan L, Deng K, Gao H, Xing S, Capoferri AA, Durand CM, Rabi SA, Laird GM, Kim M, Hosmane NN, Yang HC, Zhang H, Margolick JB, Li L, Cai W, et al. Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4(+) T Cells Permissive for Latent HIV-1 Infection. Immunity. 47: 766-775.e3. PMID 29045905 DOI: 10.1016/J.Immuni.2017.09.014 |
0.789 |
|
| 2017 |
Liu CH, Chen YS, Wang SS, Liu CJ, Su TH, Yang HC, Hong CM, Chen PJ, Chen DS, Kao JH. Sofosbuvir-based interferon-free direct acting antiviral regimens for heart transplant recipients with chronic hepatitis C virus infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29020359 DOI: 10.1093/Cid/Cix787 |
0.357 |
|
| 2017 |
Papatheodoridis GV, Manolakopoulos S, Su TH, Siakavellas S, Liu CJ, Kourikou A, Yang HC, Kao JH. Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B. Hepatology (Baltimore, Md.). PMID 28859219 DOI: 10.1002/Hep.29497 |
0.323 |
|
| 2017 |
Tseng TC, Liu CJ, Su TH, Yang WT, Chen CL, Yang HC, Wang CC, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma. The American Journal of Gastroenterology. PMID 28853728 DOI: 10.1038/Ajg.2017.254 |
0.333 |
|
| 2017 |
Liu CH, Liu CJ, Su TH, Yang HC, Hong CM, Tseng TC, Chen PJ, Chen DS, Kao JH. Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan. Journal of Gastroenterology and Hepatology. PMID 28762541 DOI: 10.1111/Jgh.13912 |
0.392 |
|
| 2017 |
Yang HC, Chen PJ. The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA. Virus Research. PMID 28627393 DOI: 10.1016/J.Virusres.2017.06.010 |
0.362 |
|
| 2017 |
Liu CH, Liu CJ, Hong CM, Su TH, Yang HC, Chen KM, Huang YP, Yeh YM, Tien HL, Liu YC, Kao JH, Chen DS, Chen PJ. A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients. Journal of Gastroenterology and Hepatology. PMID 28548299 DOI: 10.1111/Jgh.13834 |
0.359 |
|
| 2017 |
Liu CH, Liu CJ, Su TH, Fang YJ, Yang HC, Chen PJ, Chen DS, Kao JH. Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection. Open Forum Infectious Diseases. 4: ofx028. PMID 28480296 DOI: 10.1093/Ofid/Ofx028 |
0.418 |
|
| 2017 |
Yang H, Tsou H, Pei S, Chang C, Chen J, Yao M, Lin S, Lin J, Liu T, Chen P, Cheng A, Hsu C. Prediction of hepatitis B virus reactivation in lymphoma patients with resolved hepatitis B virus infection who received rituximab-containing chemotherapy: the roles of antiHBc/antiHBs quantification Journal of Hepatology. 66: S259. DOI: 10.1016/S0168-8278(17)30827-9 |
0.316 |
|
| 2016 |
Liu WL, Yang HC, Hsu CS, Wang CC, Wang TS, Kao JH, Chen DS. Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway. Proceedings of the National Academy of Sciences of the United States of America. PMID 27930338 DOI: 10.1073/Pnas.1618517114 |
0.311 |
|
| 2016 |
Tseng TC, Yang HC, Kao JH. More viral mutants, less HBsAg clearance? One size may not fit all. Gut. PMID 27797942 DOI: 10.1136/Gutjnl-2016-313027 |
0.383 |
|
| 2016 |
Yang WT, Wu LW, Tseng TC, Chen CL, Yang HC, Su TH, Wang CC, Kuo SF, Liu CH, Chen PJ, Chen DS, Liu CJ, Kao JH. Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection. Medicine. 95: e2995. PMID 26962809 DOI: 10.1097/Md.0000000000002995 |
0.364 |
|
| 2016 |
Yang HC, Kao JH. Looking into the crystal ball: biomarkers for outcomes of HBV infection. Hepatology International. PMID 26732689 DOI: 10.1007/S12072-015-9698-X |
0.357 |
|
| 2016 |
Lin CL, Yang HC, Kao JH. Hepatitis B virus: new therapeutic perspectives. Liver International : Official Journal of the International Association For the Study of the Liver. 36: 85-92. PMID 26725903 DOI: 10.1111/Liv.13003 |
0.434 |
|
| 2015 |
Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH. Hepatitis C virus infection increases the risk of lymphoid-neoplasms: A population-based cohort study. Hepatology (Baltimore, Md.). PMID 26662347 DOI: 10.1002/Hep.28387 |
0.331 |
|
| 2015 |
Liu CH, Sheng WH, Sun HY, Hsieh SM, Lo YC, Liu CJ, Su TH, Yang HC, Liu WC, Chen PJ, Chen DS, Hung CC, Kao JH. Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study. Scientific Reports. 5: 17410. PMID 26616669 DOI: 10.1038/Srep17410 |
0.383 |
|
| 2015 |
Liu CH, Huang CF, Liu CJ, Dai CY, Huang JF, Lin JW, Liang CC, Yang SS, Lin CL, Su TH, Yang HC, Chen PJ, Chen DS, Chuang WL, Kao JH, et al. Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial. Scientific Reports. 5: 11710. PMID 26130141 DOI: 10.1038/Srep11710 |
0.315 |
|
| 2015 |
Cheng HR, Kao JH, Wu HL, Tseng TC, Liu CH, Yang HC, Su TH, Chen PJ, Chen DS, Liu CJ. Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection. Hepatology International. 9: 35-42. PMID 25788377 DOI: 10.1007/S12072-014-9591-Z |
0.354 |
|
| 2015 |
Liu CH, Liang CC, Liu CJ, Lin CL, Su TH, Yang HC, Chen PJ, Chen DS, Kao JH. Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping. Journal of Clinical Microbiology. 53: 1754-7. PMID 25740780 DOI: 10.1128/Jcm.03548-14 |
0.334 |
|
| 2015 |
Yang HC, Kao JH. Viral hepatitis. HBV cure--can we pin our hopes on immunotherapy? Nature Reviews. Gastroenterology & Hepatology. 12: 129-31. PMID 25623202 DOI: 10.1038/Nrgastro.2015.8 |
0.379 |
|
| 2015 |
Liang CC, Liu CH, Chung CS, Lin CK, Su TH, Yang HC, Liu CJ, Chen PJ, Chen DS, Kao JH. Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy. The Journal of Infectious Diseases. 211: 1429-36. PMID 25387585 DOI: 10.1093/Infdis/Jiu630 |
0.356 |
|
| 2015 |
Tseng TC, Liu CJ, Yang HC, Chen CL, Yang WT, Tsai CS, Kuo SF, Verbree FC, Su TH, Wang CC, Liu CH, Chen PJ, Chen DS, Kao JH. Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. Gut. 64: 292-302. PMID 24763132 DOI: 10.1136/Gutjnl-2014-306977 |
0.322 |
|
| 2015 |
Liu CH, Liu CJ, Huang CF, Lin JW, Dai CY, Liang CC, Huang JF, Hung PH, Tsai HB, Tsai MK, Lee CY, Chen SI, Yang SS, Su TH, Yang HC, et al. Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial. Gut. 64: 303-11. PMID 24747867 DOI: 10.1136/Gutjnl-2014-307080 |
0.371 |
|
| 2014 |
Yang HC, Kao JH. Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance. Emerging Microbes & Infections. 3: e64. PMID 26038757 DOI: 10.1038/Emi.2014.64 |
0.448 |
|
| 2014 |
Kim M, Hosmane NN, Bullen CK, Capoferri A, Yang HC, Siliciano JD, Siliciano RF. A primary CD4(+) T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescence. Nature Protocols. 9: 2755-70. PMID 25375990 DOI: 10.1038/Nprot.2014.188 |
0.674 |
|
| 2014 |
Lin SR, Yang HC, Kuo YT, Liu CJ, Yang TY, Sung KC, Lin YY, Wang HY, Wang CC, Shen YC, Wu FY, Kao JH, Chen DS, Chen PJ. The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo. Molecular Therapy. Nucleic Acids. 3: e186. PMID 25137139 DOI: 10.1038/Mtna.2014.38 |
0.374 |
|
| 2014 |
Wu HL, Kao JH, Chen TC, Wu WH, Liu CH, Su TH, Yang HC, Chen DS, Chen PJ, Liu CJ. Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: clinical and mechanistic implications. Journal of Gastroenterology and Hepatology. 29: 1629-36. PMID 24730549 DOI: 10.1111/Jgh.12606 |
0.381 |
|
| 2014 |
Tseng TC, Liu CJ, Yang WT, Chen CL, Yang HC, Su TH, Wang CC, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters. Journal of Gastroenterology and Hepatology. 29: 1242-9. PMID 24384028 DOI: 10.1111/Jgh.12502 |
0.381 |
|
| 2014 |
Shan L, Xing S, Yang HC, Zhang H, Margolick JB, Siliciano RF. Unique characteristics of histone deacetylase inhibitors in reactivation of latent HIV-1 in Bcl-2-transduced primary resting CD4+ T cells. The Journal of Antimicrobial Chemotherapy. 69: 28-33. PMID 23999005 DOI: 10.1093/Jac/Dkt338 |
0.796 |
|
| 2014 |
Su TH, Liu CJ, Yang HC, Jeng YM, Cheng HR, Liu CH, Tseng TC, Ling TY, Chen PJ, Chen DS, Kao JH. Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy. Journal of Gastroenterology. 49: 356-62. PMID 23736797 DOI: 10.1007/S00535-013-0840-Z |
0.329 |
|
| 2014 |
Liu C, Wu L, Tseng T, Yang W, Su T, Yang H, Liu C, Kao J, Chen D, Chen P. P639 SPONTANEOUS SEROCLEARANCE OF HBsAg IN HEPATITIS B VIRUS/HEPATITIS C VIRUS DUALLY INFECTED PATIENTS: A 10-YEAR FOLLOW-UP Journal of Hepatology. 60: S281. DOI: 10.1016/S0168-8278(14)60801-1 |
0.32 |
|
| 2013 |
Liu CH, Huang CF, Liu CJ, Dai CY, Liang CC, Huang JF, Hung PH, Tsai HB, Tsai MK, Chen SI, Lin JW, Yang SS, Su TH, Yang HC, Chen PJ, et al. Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial. Annals of Internal Medicine. 159: 729-38. PMID 24297189 DOI: 10.7326/0003-4819-159-11-201312030-00005 |
0.324 |
|
| 2013 |
Tseng TC, Liu CJ, Chen CL, Yang HC, Su TH, Wang CC, Yang WT, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers. The Journal of Infectious Diseases. 208: 584-93. PMID 23656977 DOI: 10.1093/Infdis/Jit209 |
0.361 |
|
| 2013 |
Su TH, Liu CJ, Tseng TC, Liu CH, Yang HC, Chen CL, Chen PJ, Kao JH, Chen DS. Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection. Plos One. 8: e55916. PMID 23437072 DOI: 10.1371/Journal.Pone.0055916 |
0.409 |
|
| 2013 |
Yu ML, Lee CM, Chen CL, Chuang WL, Lu SN, Liu CH, Wu SS, Liao LY, Kuo HT, Chao YC, Tung SY, Yang SS, Kao JH, Su WW, Lin CL, ... Yang HC, et al. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up. Hepatology (Baltimore, Md.). 57: 2135-42. PMID 23322699 DOI: 10.1002/Hep.26266 |
0.364 |
|
| 2013 |
Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Hsu CA, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads. Hepatology (Baltimore, Md.). 57: 441-50. PMID 22941922 DOI: 10.1002/Hep.26041 |
0.368 |
|
| 2012 |
Tseng TC, Liu CJ, Su TH, Yang HC, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Young chronic hepatitis B patients with nucleos(t)ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivation. The Journal of Infectious Diseases. 206: 1521-31. PMID 22966125 DOI: 10.1093/Infdis/Jis569 |
0.373 |
|
| 2012 |
Liu WL, Yang HC, Su WC, Wang CC, Chen HL, Wang HY, Huang WH, Chen DS, Lai MY. Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathway. Plos One. 7: e43824. PMID 22962590 DOI: 10.1371/Journal.Pone.0043824 |
0.341 |
|
| 2012 |
Shan L, Deng K, Shroff NS, Durand CM, Rabi SA, Yang HC, Zhang H, Margolick JB, Blankson JN, Siliciano RF. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity. 36: 491-501. PMID 22406268 DOI: 10.1016/J.Immuni.2012.01.014 |
0.797 |
|
| 2012 |
Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology. 142: 1140-1149.e3; quiz e. PMID 22333950 DOI: 10.1053/J.Gastro.2012.02.007 |
0.348 |
|
| 2012 |
Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load. Hepatology (Baltimore, Md.). 55: 68-76. PMID 21858846 DOI: 10.1002/Hep.24615 |
0.358 |
|
| 2011 |
Xing S, Bullen CK, Shroff NS, Shan L, Yang HC, Manucci JL, Bhat S, Zhang H, Margolick JB, Quinn TC, Margolis DM, Siliciano JD, Siliciano RF. Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation. Journal of Virology. 85: 6060-4. PMID 21471244 DOI: 10.1128/Jvi.02033-10 |
0.802 |
|
| 2011 |
Shan L, Yang HC, Rabi SA, Bravo HC, Shroff NS, Irizarry RA, Zhang H, Margolick JB, Siliciano JD, Siliciano RF. Influence of host gene transcription level and orientation on HIV-1 latency in a primary-cell model. Journal of Virology. 85: 5384-93. PMID 21430059 DOI: 10.1128/Jvi.02536-10 |
0.775 |
|
| 2011 |
Yang HC. Primary cell models of HIV latency. Current Opinion in Hiv and Aids. 6: 62-7. PMID 21242895 DOI: 10.1097/Coh.0B013E3283412568 |
0.51 |
|
| 2010 |
Lin YJ, Huang LR, Yang HC, Tzeng HT, Hsu PN, Wu HL, Chen PJ, Chen DS. Hepatitis B virus core antigen determines viral persistence in a C57BL/6 mouse model. Proceedings of the National Academy of Sciences of the United States of America. 107: 9340-5. PMID 20439715 DOI: 10.1073/Pnas.1004762107 |
0.36 |
|
| 2010 |
Szeto GL, Brice AK, Yang HC, Barber SA, Siliciano RF, Clements JE. Minocycline attenuates HIV infection and reactivation by suppressing cellular activation in human CD4+ T cells. The Journal of Infectious Diseases. 201: 1132-40. PMID 20205570 DOI: 10.1086/651277 |
0.731 |
|
| 2009 |
Yang HC, Xing S, Shan L, O'Connell K, Dinoso J, Shen A, Zhou Y, Shrum CK, Han Y, Liu JO, Zhang H, Margolick JB, Siliciano RF. Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. The Journal of Clinical Investigation. 119: 3473-86. PMID 19805909 DOI: 10.1172/Jci39199 |
0.775 |
|
| 2009 |
Yang HC, Shen L, Siliciano RF, Pomerantz JL. Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation. Proceedings of the National Academy of Sciences of the United States of America. 106: 6321-6. PMID 19336585 DOI: 10.1073/Pnas.0809536106 |
0.714 |
|
| 2008 |
Han Y, Lin YB, An W, Xu J, Yang HC, O'Connell K, Dordai D, Boeke JD, Siliciano JD, Siliciano RF. Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. Cell Host & Microbe. 4: 134-46. PMID 18692773 DOI: 10.1016/J.Chom.2008.06.008 |
0.768 |
|
| 2008 |
Zhou Y, Shen L, Yang HC, Siliciano RF. Preferential cytolysis of peripheral memory CD4+ T cells by in vitro X4-tropic human immunodeficiency virus type 1 infection before the completion of reverse transcription. Journal of Virology. 82: 9154-63. PMID 18596085 DOI: 10.1128/Jvi.00773-08 |
0.709 |
|
| 2008 |
Chase AJ, Yang HC, Zhang H, Blankson JN, Siliciano RF. Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation. Journal of Virology. 82: 8307-15. PMID 18579608 DOI: 10.1128/Jvi.00520-08 |
0.748 |
|
| 2008 |
Bailey JR, O'Connell K, Yang HC, Han Y, Xu J, Jilek B, Williams TM, Ray SC, Siliciano RF, Blankson JN. Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor. Journal of Virology. 82: 7395-410. PMID 18495769 DOI: 10.1128/Jvi.00800-08 |
0.776 |
|
| 2007 |
Bailey JR, Zhang H, Wegweiser BW, Yang HC, Herrera L, Ahonkhai A, Williams TM, Siliciano RF, Blankson JN. Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape. The Journal of Infectious Diseases. 196: 50-5. PMID 17538883 DOI: 10.1086/518515 |
0.781 |
|
| 2007 |
Han Y, Wind-Rotolo M, Yang HC, Siliciano JD, Siliciano RF. Experimental approaches to the study of HIV-1 latency. Nature Reviews. Microbiology. 5: 95-106. PMID 17224919 DOI: 10.1038/Nrmicro1580 |
0.769 |
|
| 2007 |
Shen A, Yang HC, Zhou Y, Chase AJ, Boyer JD, Zhang H, Margolick JB, Zink MC, Clements JE, Siliciano RF. Novel pathway for induction of latent virus from resting CD4(+) T cells in the simian immunodeficiency virus/macaque model of human immunodeficiency virus type 1 latency. Journal of Virology. 81: 1660-70. PMID 17151130 DOI: 10.1128/Jvi.01396-06 |
0.779 |
|
| 2007 |
Blankson JN, Bailey JR, Thayil S, Yang HC, Lassen K, Lai J, Gandhi SK, Siliciano JD, Williams TM, Siliciano RF. Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. Journal of Virology. 81: 2508-18. PMID 17151109 DOI: 10.1128/Jvi.02165-06 |
0.811 |
|
| 2006 |
Bailey JR, Lassen KG, Yang HC, Quinn TC, Ray SC, Blankson JN, Siliciano RF. Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy. Journal of Virology. 80: 4758-70. PMID 16641269 DOI: 10.1128/Jvi.80.10.4758-4770.2006 |
0.813 |
|
| 2005 |
Cox AL, Mosbruger T, Mao Q, Liu Z, Wang XH, Yang HC, Sidney J, Sette A, Pardoll D, Thomas DL, Ray SC. Cellular immune selection with hepatitis C virus persistence in humans. The Journal of Experimental Medicine. 201: 1741-52. PMID 15939790 DOI: 10.1084/Jem.20050121 |
0.465 |
|
| 2002 |
Yang H, Lai M, Chen P, Kao J, Chen D. The effect of interferon plus ribavirin or interferon alone on the development of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis C Journal of Hepatology. 36: 250. DOI: 10.1016/S0168-8278(02)80900-X |
0.304 |
|
| Show low-probability matches. |